The global cell separation technology market is expected to witness significant growth over the forecast period. Rising prevalence of chronic diseases, such as cancer coupled with growth in the number of initiatives taken by various governments across the world to improve their respective domestic biotechnology industry increasing number of government initiatives taken to improve the domestic biotechnology industry are the major driving factors contributing to the market growth. Furthermore, increasing cell therapy oriented research and development globally and increasing incidences of neurodegenerative diseases are driving the demand for cell therapy to treat the root cause of these diseases. The technological developments in cell-based technology such as cell isolations, higher purity yield, time, and cost-effectiveness are the major factors expected to fuel the global cell separation market over the forecast period.
The global market is segmented on the basis of technology and application areas of cell separation technologies. The technology segment is bifurcated into gradient centrifugation and separation based on surface markers. Separation based on surface marker technology includes two different technologies which are fluorescence-activated cell sorting (FACS) and magnetic-activated cell sorting (MACS). As of 2013, the magnetic-activated cell sorting segment dominates the market owing to the accuracy level and faster results provided. Technologies such as FACS and gradient centrifugation techniques, sieving, panning, chromatography, and lab on a chip are currently under development. On the basis of application, the cell separation technology market is segmented into immunology, stem cell research, cancer research, and neuroscience research. The cancer research on cell-based technology dominates the market during the forecast period owing to the increasing incidences of cancer and other cell-based diseases worldwide.
North America dominates the market with the largest share owing to technological advances such as highly versatile cell isolation technologies. Asia Pacific witnesses the fastest growth during the forecast period due to increasing awareness of chronic diseases and growth in government initiatives to improve cell-based technology in this region. Considering the vast development in cell therapy research, several companies operating in the cell separation technology market are shifting focus from research laboratories to clinical research and translational laboratories to pitch their products such as instruments and reagents. The healthcare institutes and bioscience companies are initiating various strategies such as collaborations, acquisitions, and expansions to maintain a competitive environment in the cell separation technology market. Some of the major players in the cell separation technology market include PluriSelect GmbH, Life Technologies (Thermo Fischer Scientific, Inc.) STEMCELL Technologies, Mitenyi Biotec, EMD Millipore, and BD Bioscience.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.